US Patent Issued to GENMAB, MSD INTERNATIONAL on June 10 for "Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugate" (American, Dutch Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,841, issued on June 10, was assigned to GENMAB A/S (Valby, Denmark) and MSD INTERNATIONAL GMBH (Luzerne, Switzerland).

"Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugate" was invented by Reshma Abdulla Rangwala (Philadelphia), Esther C. W. Breij (Driebergen, Netherlands), Sandra Verploegen (Nieuwegein, Netherlands), Oyewale O. Abidoye (Bellevue, Wash.), Leonardo Viana Nicacio (Redmond, Wash.), Anthony Cao (Sammamish, Wash.) and Shyra Gardai (Bothell, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an anti-PD-1 antibody comprising the complementary dete...